Economic Impact by using faster pathogen detection methods

The current COVID-19 pandemic made evident to all that Health is linked to Economy with tighter links than we might think. Health is not the power drainer of national budgets worldwide; it is also the stabilizer of economic growth and abundance. It is a reciprocal equation and is not only limited to humans. A deadly herd epidemic is enough to devastate a nation’s economy for years; an infected grooming product is enough to bring down big economic giants; a food poisoning can defame a large food chain and result in huge pay-outs.

Read More about Economic Impact by using faster pathogen detection methods

SEPSIS: WHEN TIME MATTERS

Every year, about 48 million people are diagnosed with sepsis worldwide. 1 out of 5 people with sepsis die – and this represents 18 to 20% of annual global deaths. Almost half of these are children, with neonatal and pediatric sepsis accounting for 20 million cases. These are devastating numbers.

The Asia-Pacific region has the highest incidence of sepsis in the world – estimates have revealed that up to 1600 per 100,000 people are afflicted with the disease. The death rate in these countries reach as high as 35%

Read More about SEPSIS: WHEN TIME MATTERS

CAN SEPSIS PATIENTS BENEFIT FROM NGS IN CLINICAL SETTINGS?

Sepsis is the final common pathway to death for severe infectious diseases

Sepsis is responsible for almost 20% of all deaths worldwide. This was higher than deaths caused by cancer in 2020. Even if patients survive to live another day, they have risks of developing long-term consequences of neurological, psychiatric, and functional disabilities. Sepsis costs a total of $13,4 billion in 2018, more than twice its cost in 2012 as reported by US Medicare. Sepsis is undoubtedly still a complex challenge up till now.

Read More about CAN SEPSIS PATIENTS BENEFIT FROM NGS IN CLINICAL SETTINGS?

Decoding the Unknown: use of clinical metagenomics to effectively diagnose infectious diseases

Micronbrane Medical in partnership with Front Line Genomics sponsored Webinar series on Clinical Microbiology which took place on 14th of July . The webinar covers existing and novel developments in the use of molecular and genomic approaches to clinical microbiology. Watch Professor John Rossen (University of Utah) shares about latest advances in pathogen identification and analysis and show clinical metagenomics application to effectively diagnose infectious diseases.